RWE AG (OTCMKTS:RWEOY – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 44,003 shares, an increase of 84.1% from the August 31st total of 23,903 shares. Based on an average daily trading volume, of 168,305 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
RWEOY has been the subject of a number of analyst reports. Morgan Stanley restated an “overweight” rating on shares of RWE in a research report on Thursday, July 23rd. Citigroup reiterated a “neutral” rating on shares of RWE in a research note on Wednesday, July 29th. Royal Bank Of Canada reissued an “outperform” rating on shares of RWE in a report on Monday, August 17th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of RWE in a report on Monday, August 17th. Three equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $53.30.
View Our Latest Research Report on RWEOY
RWE Trading Up 0.4%
About RWE
RWE AG is a Germany-based energy company engaged in the generation, trading and supply of electricity. Its business is centered on renewable energy, including onshore and offshore wind, solar power and battery storage, supported by flexible generation and energy trading activities.
The company develops, builds and operates energy projects and provides electricity-related services to commercial and residential customers through its supply businesses. RWE has also pursued technologies intended to support the energy transition, including green hydrogen and other lower-carbon energy solutions.
RWE traces its origins to the formation of Rheinisch-Westfälisches Elektrizitätswerk in 1898.
See Also
- Five stocks we like better than RWE
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
- 3 Healthcare Dividend Stocks Offering More Than Just Income
Receive News & Ratings for RWE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RWE and related companies with MarketBeat.com's FREE daily email newsletter.
